Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1429
Full metadata record
DC FieldValueLanguage
dc.contributor.authorREG. NO. BIO120002-
dc.date.accessioned2023-06-24T07:05:35Z-
dc.date.available2023-06-24T07:05:35Z-
dc.date.issued2023-06-15-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/1429-
dc.description.abstractBackground: Fungal sepsis in neonates is on rise among blood stream infection, it is the third most common etiological agent for sepsis and the changing epidemiology to non-albicans Candida is grossly evident. Fungal isolates are showing azole resistance which were the most common prophylactic treatment used, now made treatment choices difficult for neonate ICU clinicians. Newer class of antifungal drugs especially Echinocandins (Caspofungin) came into real time practice in azole resistant Candida causing sepsis. Objective: 1. To study the prevalence of Candidemia in high-risk neonates of NICU 2. To study Caspofungin (Echinocandin) antifungal susceptibility in Fluconazole resistant Candida isolates by E test / MIC test strip method.en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectFungal sepsis, Candida, NAC species, critically ill high-risk neonates.en_US
dc.titleprevalence of candidemia in high-risk neonates of neonatal intensive care unit -a one-year cross sectional study.en_US
dc.typeDissertationsen_US
Appears in Collections:Microbiology

Files in This Item:
File Description SizeFormat 
BIO120002.pdf10.84 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.